Trulieve Cannabis surges 8% on DEA federal registration

Trulieve Cannabis (TRLV.US) surged nearly 8% during regular trading to $11.96.

The company announced that its state-licensed medical cannabis business has obtained federal registration from the U.S. Drug Enforcement Administration. This follows the DEA's issuance of initial federal registrations to eligible state-licensed clinics after the attorney general ordered a new federal framework in April, subsequent to the rescheduling of medical cannabis to Schedule III under the Controlled Substances Act.

Based on public media reports. AI-generated; not investment advice.